ESR1 and breast carcinoma: Similarly, Varley et al. found two recurrent read-through fusion transcripts, SCNN1A-TNFRSF1A and CTSD-IFITM10, that were present in breast cancer cell lines and estrogen receptor positive (ER+) breast primary tumor tissues, but not in normal breast tissues [11].